2023 was a troublesome 12 months to the biopharma market, with several firms downsizing and restructuring their workforces to stay afloat. You will find signs of Restoration, as mergers and acquisitions picked up over the pharmaceutical and lifetime sciences field in the latter part of 2023 and possess continued their https://sites.google.com/view/bio-sites/blog